Adaptin Bio, Inc. APTN
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.71M | 3.83M | 3.64M | 3.12M | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.39M | 5.71M | 5.42M | 4.56M | -- |
| Operating Income | -5.39M | -5.71M | -5.42M | -4.56M | -- |
| Income Before Tax | -5.40M | -5.71M | -5.17M | -4.66M | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.40 | -5.71 | -5.17 | -4.66 | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.40M | -5.71M | -5.17M | -4.66M | -- |
| EBIT | -5.39M | -5.71M | -5.42M | -4.56M | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.63 | -0.67 | -0.64 | -0.75 | -- |
| Normalized Basic EPS | -0.39 | -0.42 | -0.44 | -0.46 | -- |
| EPS Diluted | -0.63 | -0.67 | -0.65 | -0.75 | -- |
| Normalized Diluted EPS | -0.39 | -0.42 | -0.44 | -0.46 | -- |
| Average Basic Shares Outstanding | 34.49M | 34.09M | 31.22M | 25.99M | -- |
| Average Diluted Shares Outstanding | 34.49M | 34.09M | 31.22M | 25.99M | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |